Please login to the form below

Not currently logged in
Email:
Password:

Former Sanofi exec Joseph Devaney joins Astellas

He becomes government affairs and policy, Americas VP

Astellas Joseph DevaneyAstellas has appointed Joseph Devaney as vice president of government affairs and policy for its Americas business.

In this role, Devaney will be responsible for developing, communicating and implementing Astellas' federal and state government strategies in the US, as well as overseeing its engagement activities and policy development.

He joins the Japanese pharmaceutical firm from Sanofi, where he spent the last 20 years in a series of senior positions, including his most recent post as vice president of federal and state relations.

Prior to this, Devaney was director of state government affairs for Sandoz, which joined Novartis in 1996, and served as a research director and chief of staff for the New Jersey General Assembly.

Jeffrey Winton, senior vice president of corporate affairs at Astellas, said: “Joe's experience and leadership will elevate our highly collaborative team of senior government strategy, policy, legislative and regulatory professionals in Washington, DC.

“His role in developing Astellas' strategy on public policy issues being considered by government lawmakers and trade associations will be pivotal in Astellas' growth throughout the Americas.”

13th July 2016

From: Regulatory

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
The Good Ideas Group

Remarkable but responsible creative work. We're most passionate about the pursuit of original, powerful ideas that our clients can harness...

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....